Pregled bibliografske jedinice broj: 305654
The influence of -2518 A/G MCP-1 promoter polymorphism on homocysteine concentrations in patients with coronary artery disease
The influence of -2518 A/G MCP-1 promoter polymorphism on homocysteine concentrations in patients with coronary artery disease // Clinical Chemistry and Laboratory Medicine / Gerard Siest (ur.).
Amsterdam: Walter de Gruyter, 2007. (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 305654 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The influence of -2518 A/G MCP-1 promoter polymorphism on homocysteine concentrations in patients with coronary artery disease
Autori
Gršković, Branka ; Pašalić, Daria ; Marinković, Natalija ; Ferenčak, Goran ; Stavljenić Rukavina, Ana
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Clinical Chemistry and Laboratory Medicine
/ Gerard Siest - Amsterdam : Walter de Gruyter, 2007
Skup
EUROMEDLAB Amsterdam 2007 17th IFCC-FESCC European Congress of Clinical Chemistry and Laboratory Medicine 60th National Congress of the Netherlands Society for Clinical Chemistry and Laboratory
Mjesto i datum
Amsterdam, Nizozemska, 03.06.2007. - 07.06.2007
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
Monocyte chemoattractant protein (MCP)-1; polymorphism; coronary artery disease
(chemoattractant protein (MCP)-; polymorphism; coronary artery disease)
Sažetak
Background. Monocyte chemoattractant protein (MCP)-1 is the key chemokine in the process of atherosclerotic vascular inflammation. MCP-1 and its receptor CCR2 have already been proposed as candidate genes for studies of genetic markers in coronary artery disease (CAD). Methods. The identification of the promoter polymorphism -2518 A/G was carried out using PCR, followed by a restriction fragment length polymorphism (RFLP) assay, using a PvuII site, which is introduced by the presence of the G nucleotide. Genotyping was performed in patients with (+) and without (-) angiographically confirmed CAD. Serum concentrations of CRP were determined by immunonephelometry, and homocysteine using fluorescence polarisation immunoassay (FPIA). Results. Statistically significant diference was not observed between the absolute frequencies of MCP-1 -2518 A/G gene polymorphism and CAD+ and CAD- subjects, p=0.913. The frequencies of MCP-1 -2518 AA, AG and GG genotypes were 69, 63 and 7 in CAD+ group, and 38, 35 and 5 in CAD- group, respectively. Statistically significant difference was found for median homocysteine concentrations between the MCP-1 genotypes in CAD- group, p=0.035. Median CRP concentrations were not statistically significant in both groups studied. After the corrections for sex and gender, statistically significant difference was found for median homocysteine concentrations in CAD+ (p=0.013) and CAD- (p=0.04) groups. Median CRP concentrations were not significantly different after the corrections for sex and gender in both groups studied. Conclusion. Homocysteine concentrations are significantly correlated with MCP-1 gene variants which confirm the importance of this polymorphism in genetics of CAD.
Izvorni jezik
Engleski
Znanstvena područja
Javno zdravstvo i zdravstvena zaštita
POVEZANOST RADA
Projekti:
108-1080316-0298 - Molekularna osnova aterogeneze
Ustanove:
Medicinski fakultet, Zagreb
Profili:
Branka Gršković
(autor)
Daria Pašalić
(autor)
Goran Ferenčak
(autor)
Ana Stavljenić
(autor)
Natalija Marinković
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE